I joined the ENDOMIC team in October 2024 as a study engineer to work on the development of cellular models to explore the pathogenic role of autoantibodies in systemic sclerosis. The objective is to study the effects of immunoglobulin G from patients with systemic sclerosis on healthy endothelial and fibroblast cell models using multi-omics analyses. Subsequently, we will attempt to establish a murine passive transfer model.